Shamonda finding in a patient prompts an investigation
· BehindLines newsroom
French authorities announced on 22 October that Shamonda virus had been identified in a patient receiving treatment in Lyon for a serious illness and suffering from severe immunosuppression. The patient died early in the month. Associated Press reported this first detection in a human, which was also confirmed by the European Centre for Disease Prevention and Control (ECDC).
Separating detection from the investigation's conclusions
The French statement describes the case as exceptional. Although the virus has circulated in animals in Africa and Asia for decades, no human infection had previously been documented. Authorities say that, on the basis of current knowledge, no health risk to the general population has been identified at this stage.
How the patient became infected is still under investigation. French investigators consider a bite from a Culicoides midge in eastern France the leading hypothesis. They also believe the virus was very probably linked to the brain complications that occurred before the patient died. These findings remain provisional.
The ECDC says the investigation must establish how the infection was acquired and whether the virus caused or contributed to the death. Detecting the virus and determining its possible role in the patient's subsequent condition are therefore separate questions.
Monitoring people and animals
Shamonda was detected in European livestock during the summer of 2026. According to the ECDC, the earliest signs in animals were observed in June, followed by identification of the virus in late July. Detections were subsequently reported in several countries.
In animals, transmission usually occurs through biting midges. The ECDC stresses that the precise species involved in this human case is not yet known.
The European centre is working with French authorities, its partners and the relevant European reference laboratory to strengthen diagnostic capacity and help identify any further infections. In France, the investigation brings together expertise in human, animal and environmental health. Its findings are still awaited.